How Cost‐Effectiveness Impacts Treatment Choice in Irritable Bowel Syndrome: A Cost‐Effectiveness Analysis of Guideline Recommended Over‐the‐Counter Treatments and Low FODMAP Diet From a Patient Perspective: 1132. (October 2017)